Treatment of Lupus in NZB/W F1 Mice with Monoclonal Antibody Against Fas Ligand
- 31 March 2000
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 14 (2) , 151-157
- https://doi.org/10.1006/jaut.1999.0356
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 36 references indexed in Scilit:
- Agonistic anti-Fas antibodies induce glomerular cell apoptosis in mice in vivoKidney International, 1997
- Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.Journal of Clinical Investigation, 1996
- Fas Ligand-Induced Apoptosis as a Mechanism of Immune PrivilegeScience, 1995
- A role for CD95 ligand in preventing graft rejectionNature, 1995
- Mutations in Fas Associated with Human Lymphoproliferative Syndrome and AutoimmunityScience, 1995
- Fas and Fas ligand: lpr and gld mutationsImmunology Today, 1995
- The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic miceImmunity, 1994
- The apoptosis-1/Fas protein in human systemic lupus erythematosus.Journal of Clinical Investigation, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Effects of major histocompatibility complex on autoimmune disease of H-2-congenic New Zealand MiceInternational Immunology, 1990